References
- Howell, B.A., Siler, S.Q., Barton, H.A., Joshi, E.M., Cabal, A., Eichenbaum, G., Watkins, P.B., 2016. Development of quantitative systems pharmacology and toxicology models within consortia: experiences and lessons learned through DILIsym development. Drug Discov. Today Dis. Models, Computational Models of Liver Disease 2016 22, 5–13. doi: 10.1016/j.ddmod.2017.04.001.
- Jucaite, A., Svenningsson, P., Rinne, J.O., Cselényi, Z., Varnäs, K., Johnström, P., Amini, N., Kirjavainen, A., Helin, S., Minkwitz, M., Kugler, A.R., Posener, J.A., Budd, S., Halldin, C., Varrone, A., Farde, L., 2015. Effect of the myeloperoxidase inhibitor AZD3241 on microglia: a PET study in Parkinson’s disease. Brain 138, 2687–2700. doi: 10.1093/brain/awv184.
- Lefkowitz, D.L., Lefkowitz, S.S., 2008. Microglia and myeloperoxidase: A deadly partnership in neurodegenerative disease. Free Radic. Biol. Med. 45, 726–731. doi: 10.1016/j.freeradbiomed.2008.05.021.
- Longo, D.M., Shoda, L.K.M., Howell, B.A., Coric, V., Berman, R.M., Qureshi, I.A., 2020. Assessing Effects of BHV-0223 40 mg Zydis® Sublingual Formulation and Riluzole 50 mg Oral Tablet on Liver Function Test Parameters Utilizing DILIsym®. Toxicol. Sci. Off. J. Soc. Toxicol. doi: 10.1093/toxsci/kfaa019.
- Longo, D.M., Woodhead, J.L., Walker, P., Herédi-Szabó, K., Mogyorósi, K., Wolenski, F.S., Dragan, Y.P., Mosedale, M., Siler, S.Q., Watkins, P.B., Howell, B.A., 2019. Quantitative Systems Toxicology Analysis of In Vitro Mechanistic Assays Reveals Importance of Bile Acid Accumulation and Mitochondrial Dysfunction in TAK-875-Induced Liver Injury. Toxicol. Sci. Off. J. Soc. Toxicol. 167, 458–467. doi: 10.1093/toxsci/kfy253.
- Senior, J.R., 2014. Evolution of the Food and Drug Administration Approach to Liver Safety Assessment for New Drugs: Current Status and Challenges. Drug Saf. 37, 9–17. doi: 10.1007/s40264-014-0182-7.
- Smith, B., Rowe, J., Watkins, P.B., Ashina, M., Woodhead, J.L., Sistare, F.D., Goadsby, P.J., 2020. Mechanistic Investigations Support Liver Safety of Ubrogepant. Toxicol. Sci. Off. J. Soc. Toxicol. 177, 84–93. doi: 10.1093/toxsci/kfaa093.
- Stefanova, N., Georgievska, B., Eriksson, H., Poewe, W., Wenning, G.K., 2012. Myeloperoxidase Inhibition Ameliorates Multiple System Atrophy-Like Degeneration in a Transgenic Mouse Model. Neurotox. Res. 21, 393–404. doi: 10.1007/s12640-011-9294-3.
- Tong, X., Zhou, D., Savage, A., Mullen, J.A., Li, Y., Taylor, W., Li, J., Al-Huniti, N., Xu, H., 2018. Population Pharmacokinetic Modeling With Enterohepatic Circulation for AZD3241 in Healthy Subjects and Patients With Multiple System Atrophy. J. Clin. Pharmacol. 58, 1452–1460. doi: 10.1002/jcph.1134.
- Woodhead, J.L., Siler, S.Q., Howell, B.A., Watkins, P.B., Conway, C., 2022. Comparing the Liver Safety Profiles of 4 Next-Generation CGRP Receptor Antagonists to the Hepatotoxic CGRP Inhibitor Telcagepant Using Quantitative Systems Toxicology Modeling. Toxicol. Sci. Off. J. Soc. Toxicol. 188, 108–116. doi: 10.1093/toxsci/kfac051.
- Woodhead, J.L., Watkins, P.B., Howell, B.A., Siler, S.Q., Shoda, L.K.M., 2017. The role of quantitative systems pharmacology modeling in the prediction and explanation of idiosyncratic drug-induced liver injury. Drug Metab. Pharmacokinet. 32, 40–45. doi: 10.1016/j.dmpk.2016.11.008.
- Woodhead, J.L., Yang, K., Oldach, D., MacLauchlin, C., Fernandes, P., Watkins, P.B., Siler, S.Q., Howell, B.A., 2019. Analyzing the Mechanisms Behind Macrolide Antibiotic-Induced Liver Injury Using Quantitative Systems Toxicology Modeling. Pharm. Res. 36, 48. doi: 10.1007/s11095-019-2582-y.
- Xiong, L., McCoy, M., Komuro, H., West, X.Z., Yakubenko, V., Gao, D., Dudiki, T., Milo, A., Chen, J., Podrez, E.A., Trapp, B., Byzova, T.V., 2022. Inflammation-dependent oxidative stress metabolites as a hallmark of amyotrophic lateral sclerosis. Free Radic. Biol. Med. 178, 125–133. doi: 10.1016/j.freeradbiomed.2021.11.031.